Geneos Wealth Management Inc. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 90 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,630
-25.5%
1,0000.0%0.00%
Q2 2023$3,530
+14.2%
1,0000.0%0.00%
Q1 2023$3,090
-27.0%
1,0000.0%0.00%
Q4 2022$4,230
+111.5%
1,0000.0%0.00%
Q3 2022$2,0000.0%1,0000.0%0.00%
Q2 2022$2,0000.0%1,0000.0%0.00%
Q1 2022$2,000
-33.3%
1,0000.0%0.00%
Q4 2021$3,000
-50.0%
1,0000.0%0.00%
Q3 2021$6,000
-25.0%
1,0000.0%0.00%
Q2 2021$8,000
-11.1%
1,0000.0%0.00%
Q1 2021$9,0000.0%1,0000.0%0.00%
Q4 2020$9,0000.0%1,0000.0%0.00%
Q3 2020$9,000
-10.0%
1,0000.0%0.00%
-100.0%
Q2 2020$10,000
+25.0%
1,0000.0%0.00%0.0%
Q1 2020$8,0000.0%1,0000.0%0.00%
Q4 2019$8,000
-27.3%
1,0000.0%0.00%
-100.0%
Q3 2019$11,000
-8.3%
1,0000.0%0.00%0.0%
Q2 2019$12,000
-68.4%
1,0000.0%0.00%
-66.7%
Q1 2019$38,000
+8.6%
1,000
+181.7%
0.00%0.0%
Q4 2017$35,000
-23.9%
355
-8.0%
0.00%
-40.0%
Q3 2017$46,0003860.01%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,536,156$21,405,0002.24%
Palo Alto Investors LP 1,396,163$11,784,0000.99%
Camber Capital Management LP 1,950,000$16,458,0000.98%
TANG CAPITAL MANAGEMENT LLC 800,000$6,752,0000.95%
Capital Impact Advisors, LLC 147,303$1,243,0000.52%
Sofinnova Investments, Inc. 638,026$5,385,0000.50%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 963,212$8,130,0000.26%
RICE HALL JAMES & ASSOCIATES, LLC 466,482$3,937,0000.22%
PDT Partners, LLC 204,238$1,724,0000.14%
Eversept Partners, LP 58,251$491,6380.12%
View complete list of PUMA BIOTECHNOLOGY INC shareholders